You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach

Article metrics

Article menu

Download PDFPDF

XML
Epidemiology
Research
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach

 

Online download statistics by month:

Online download statistics by month: March 2019 to December 2024

AbstractFullPdf
Mar 201916511594357
Apr 201938135174
May 201927624646
Jun 201926423651
Jul 201917115125
Aug 201917315533
Oct 201915814126
Nov 201915714333
Dec 201912611329
Jan 202019217627
Feb 202012110936
Mar 2020757413
May 202010110124
Jun 202010910936
Jul 2020888322
Aug 2020786014
Sep 202011010032
Oct 2020938925
Nov 2020847115
Dec 2020807519
Jan 2021777210
Feb 2021888531
Mar 202110710029
Apr 202119118030
May 2021978331
Jun 202170667
Jul 2021827912
Aug 2021947329
Sep 2021837614
Oct 20211028943
Nov 2021423327
Dec 2021716410
Jan 202239332
Feb 202260516
Mar 202210910519
Apr 202212012111
May 20221169839
Jun 2022787719
Jul 2022857315
Aug 2022827014
Sep 2022786739
Oct 2022737212
Nov 2022625923
Dec 202258537
Jan 2023816115
Feb 202382689
Mar 2023696812
Apr 2023817615
May 2023585413
Jun 202348508
Jul 202348467
Aug 2023685916
Sep 202372726
Oct 2023727112
Nov 202355515
Dec 2023715111
Jan 2024533913
Feb 2024614615
Mar 20241229223
Apr 2024735911
May 2024867016
Jun 2024655715
Jul 2024655820
Aug 2024705718
Sep 20241431389
Oct 202412411219
Nov 2024886117
Dec 2024760
Total831475781721